
{
  "drug_name": "Rifampin",
  "tradename": "Rifadin, Rimactane, Rifocin, Rifamate, Rifater",
  "usage_and_dosing": {
    "description": "Rifampin is used clinically in the management of infections due to mycobacteria, Staph. aureus, Neisseria sp., Legionella sp. and other organisms.",
    "notes": [
      "Rifampin is often used in combination therapy both to achieve additive or synergistic antibacterial efficacy and to reduce the risk of development of resistance.",
      "Rifampin is one of the Rifamycin class of antibiotics (Rifampin, Rifabutin, Rifapentine, Rifaximin). All drugs in the class have significant and important drug-drug interactions.",
      "Caution: numerous drug interactions (see list below, not all-inclusive)."
    ],
    "adult_dose": {
      "active_m_tuberculosis": [
        "Rifampin 10 mg/kg/day po once daily (max 600 mg/day) (IV form is also available from Ben Venue Laboratories)",
        "Rifamate Combination (300 mg Rifampin / 150 mg Isoniazid). Dose as 2 tabs once daily",
        "Rifater Combination (50 mg Isoniazid / 120 mg Rifampin / 300 mg Pyrazinamide). Dose for wt >55 kg: 6 tabs once daily"
      ],
      "non_tuberculous_mycobacterial_infections": "Rifampin is used as part of multi-drug therapy: 10 mg/kg/day po once daily",
      "m_leprae": [
        "Multibacillary (Lepromatous): (Rifampin 600 mg + Clofazimine 50 mg + Dapsone 100 mg) po once daily",
        "Paucibacillary (Tuberculoid): (Rifampin 600 mg + Dapsone 100 mg) po once daily",
        "Single lesion: (Rifampin 600 mg + Ofloxacin 400 mg + Minocycline 100 mg) po x one dose (Lancet 353:655, 1999)"
      ],
      "staph_aureus": "Rifampin 600 mg po once daily (always in combination with other drugs). For risk benefit of adding Rifampin to standard therapy for the treatment of Staph. aureus native valve endocarditis: AAC 52:2463, 2008",
      "h_influenzae_meningitis_prophylaxis": "Rifampin 600 mg po once daily x 4 days",
      "n_meningitidis_meningitis_prophylaxis": "600 mg po q12h x 2 days",
      "brucellosis": "Used as part of combination therapy for the treatment of brucellosis."
    },
    "pediatric_dose": {
      "h_influenzae_prophylaxis": {
        "dose": "20 mg/kg q24h x4 days",
        "max": "600 mg"
      },
      "n_meningitidis_prophylaxis": {
        "dose": "Age <1 mon: 5 mg/kg q12h x4 doses, Infants, children: 10 mg/kg q12h x4 doses",
        "max": "600 mg"
      },
      "active_tb": {
        "dose": "10-20 mg/kg/day (once daily)",
        "max": "600 mg"
      }
    }
  },
  "renal_adjustment": {
    "body_weight_and_creatinine_clearance_calculations": true,
    "notes": [
      "Dosage adjustment may be required in hepatic disease."
    ],
    "half_life_normal": "1.5-5",
    "half_life_esrd": "up to 11",
    "dose_renal_function_normal": "600 mg po q24h",
    "dosing": [
      {
        "crcl": ">50",
        "adjustment": "No dosage adjustment"
      },
      {
        "crcl": "≤50",
        "adjustment": "300-600 mg q24h"
      },
      {
        "dialysis": "Hemodialysis",
        "adjustment": "300-600 mg q24h"
      },
      {
        "dialysis": "CAPD",
        "adjustment": "300-600 mg q24h"
      },
      {
        "dialysis": "CRRT",
        "adjustment": "300-600 mg q24h"
      },
      {
        "dialysis": "SLED",
        "adjustment": "No data"
      }
    ]
  },
  "hepatic_adjustment": {
    "note": "Some experts recommend reducing the dose in liver failure but no specific guidance is available. Monitor LFTs.",
    "mild_impairment": "No dosage adjustment",
    "moderate_impairment": "No dosage adjustment",
    "severe_impairment": "No dosage adjustment"
  },
  "other_adjustment": {
    "obesity": "See Obesity Dosing Adjustments."
  },
  "adverse_effects": {
    "effects": [
      "Potentially hepatotoxic. Use with caution in patients with impaired liver function or in patients with history of, or ongoing, excessive use of alcohol.",
      "If elevated bilirubin and/or substantive increase in liver-associated enzymes occurs, discontinue Rifampin therapy.",
      "Many potential important drug-drug interactions.",
      "Flu-like syndrome described with intermittent dosing regimens or intermittent non-compliance.",
      "Red-orange discoloration of urine, feces, saliva, sweat, tears and CSF. Can permanently stain contact lenses.",
      "Thrombocytopenia and vasculitis can occur (Ann Pharmacother 42:727, 2008). Documentation of drug-induced immune thrombocytopenia (J Thrombosis & Haemostasis 11:169, 2012)",
      "Can cause interstitial nephritis."
    ]
  },
  "pregnancy_risk": {
    "fda_risk_category": "Humans: No well-controlled studies, does not appear to be teratogenic. Animals: Teratogenic in rodents, embryotoxic in rabbits.",
    "lactation": "Probably safe, monitor infant for toxicity. Breast milk may be stained a yellow, orange, red, or brown color."
  },
  "antimicrobial_spectrum": {
    "preferred": [],
    "alternative": []
  },
  "pharmacology": {
    "pk_pd_index": "24-hr AUC/MIC",
    "preparations": "Cap (150, 300 mg) Injection",
    "food_recs": "Cap no food",
    "oral_absorption": "70-90",
    "tmax_hr": "1.5-2.0",
    "peak_serum_conc": "7 (600 mg po, SD)",
    "peak_urine_conc": "No data",
    "protein_binding": "80",
    "volume_of_distribution": "0.65 L/kg",
    "avg_serum_t1_2": "1.5-5.0",
    "elimination": "Metabolism, biliary, fecal",
    "bile_penetration": "10,000",
    "csf_blood": "7-56",
    "therapeutic_levels_in_csf": "Yes",
    "auc": "40-60 (600 mg po q24h, 0-24 hr)"
  },
  "enzyme_transporter_mediated_interactions": {
    "cyp450s_substrate": [],
    "transporters_substrate": [
      "PGP",
      "OATP1B1"
    ],
    "ugts_substrate": [],
    "cyp450s_inhibited": [],
    "transporters_inhibited": [
      "OATP1B1"
    ],
    "ugts_inhibited": [],
    "cyp450s_induced": [
      "CYP1A2",
      "CYP2B6",
      "CYP2C8",
      "CYP2C9",
      "CYP2C19",
      "CYP2D6 (weak)",
      "CYP3A4"
    ],
    "transporters_induced": [
      "PGP"
    ],
    "ugts_induced": [
      "UGT1A1",
      "UGT1A4"
    ],
    "impact_on_serum_drug_concentrations": "↓"
  },
  "major_drug_interactions": {
    "note": "Rifampin has numerous drug interactions (Refs: Arch Intern Med 162:985, 2002, Clin Pharmocokinet 42:819, 2003).",
    "interactions": [
      {
        "drug": "Amiodarone",
        "effect": "↓ amiodarone",
        "suggestion": "Monitor"
      },
      {
        "drug": "Amitriptyline",
        "effect": "↓ amitriptyline",
        "suggestion": "Adjust"
      },
      {
        "drug": "Antacids",
        "effect": "↓ rifampin",
        "suggestion": "Adjust"
      },
      {
        "drug": "Atazanavir/r",
        "effect": "↓ atazanavir, ↓ or ↑ rifampin",
        "suggestion": "Avoid"
      },
      {
        "drug": "Atovaquone",
        "effect": "↑ rifampin, ↓ atovaquone",
        "suggestion": "Adjust"
      },
      {
        "drug": "Caspofungin",
        "effect": "↓ caspofungin",
        "suggestion": "Adjust"
      },
      {
        "drug": "Chlorpropamide",
        "effect": "↓ chlorpropamide",
        "suggestion": "Adjust"
      },
      {
        "drug": "Citalopram",
        "effect": "↓ citalopram",
        "suggestion": "Monitor"
      },
      {
        "drug": "Clarithromycin",
        "effect": "↑ rifampin, ↓ clarithromycin",
        "suggestion": "Adjust"
      },
      {
        "drug": "Clindamycin",
        "effect": "↓ clindamycin (J Infect 2015;71:200)",
        "suggestion": "Monitor"
      },
      {
        "drug": "Cyclosporine",
        "effect": "↑ rifampin, ↓ cyclosporine",
        "suggestion": "Adjust"
      },
      {
        "drug": "Dapsone",
        "effect": "↓ dapsone",
        "suggestion": "Adjust"
      },
      {
        "drug": "Darunavir/r",
        "effect": "↓ darunavir, ↓ or ↑ rifampin",
        "suggestion": "Avoid"
      },
      {
        "drug": "Desipramine",
        "effect": "↓ desipramine",
        "suggestion": "Adjust"
      },
      {
        "drug": "Dexamethasone",
        "effect": "↓ rifampin, ↓ dexamethasone",
        "suggestion": "Adjust"
      },
      {
        "drug": "Diazepam",
        "effect": "↓ diazepam",
        "suggestion": "Adjust"
      },
      {
        "drug": "Digoxin",
        "effect": "↓ digoxin",
        "suggestion": "Adjust"
      },
      {
        "drug": "Dihydroartemisinin-piperaquine",
        "effect": "↓ PPQ, ↓ DHA",
        "suggestion": "Avoid"
      },
      {
        "drug": "Diltiazem",
        "effect": "↑ rifampin, ↓ diltiazem",
        "suggestion": "Adjust"
      },
      {
        "drug": "Disopyramide",
        "effect": "↓ disopyramide",
        "suggestion": "Adjust"
      },
      {
        "drug": "Divalproex",
        "effect": "↓ valproic acid (Ment Health Clin 2021;11:19)",
        "suggestion": "Monitor"
      },
      {
        "drug": "Doxycycline",
        "effect": "↓ doxycycline (AAC 1994;38:2798)",
        "suggestion": "Adjust"
      },
      {
        "drug": "Efavirenz",
        "effect": "↓ efavirenz",
        "suggestion": "Avoid"
      },
      {
        "drug": "Ethinyl estradiol",
        "effect": "↓ ethinyl estradiol",
        "suggestion": "Avoid"
      },
      {
        "drug": "Etravirine",
        "effect": "↓ etravirine",
        "suggestion": "Avoid"
      },
      {
        "drug": "Fexinidazole",
        "effect": "↑ M1, M2 (fexinidazole) metabolites",
        "suggestion": "Avoid"
      },
      {
        "drug": "Fluconazole",
        "effect": "↓ fluconazole",
        "suggestion": "Adjust"
      },
      {
        "drug": "Fluvastatin",
        "effect": "↓ fluvastatin",
        "suggestion": "Adjust"
      },
      {
        "drug": "Fusidic acid",
        "effect": "↓ fusidic acid, ↑ rifampin",
        "suggestion": "Monitor"
      },
      {
        "drug": "Haloperidol",
        "effect": "↓ haloperidol",
        "suggestion": "Adjust"
      },
      {
        "drug": "Ibrexafungerp",
        "effect": "↓ ibrexafungerp",
        "suggestion": "Avoid"
      },
      {
        "drug": "Imipramine",
        "effect": "↓ imipramine",
        "suggestion": "Adjust"
      },
      {
        "drug": "Isavuconazonium",
        "effect": "↓ isavuconazole, ↑ rifampin",
        "suggestion": "Avoid"
      },
      {
        "drug": "Itraconazole",
        "effect": "↓ itraconazole, ↑ rifampin",
        "suggestion": "Avoid"
      },
      {
        "drug": "Lamotrigine",
        "effect": "↓ lamotrigine (Br J Clin Pharmacol 2019;85:1859)",
        "suggestion": "Monitor"
      },
      {
        "drug": "Lenacapavir",
        "effect": "↓ lenacapavir",
        "suggestion": "Co-administration contraindicated"
      },
      {
        "drug": "Letermovir",
        "effect": "↓ letermovir",
        "suggestion": "Avoid"
      },
      {
        "drug": "Linezolid",
        "effect": "↓ linezolid",
        "suggestion": "Adjust"
      },
      {
        "drug": "Lorlatinib",
        "effect": "↓ lorlatinib, hepatotoxicity",
        "suggestion": "Co-administration contraindicated"
      },
      {
        "drug": "Maribavir",
        "effect": "↓ maribavir",
        "suggestion": "Avoid"
      },
      {
        "drug": "Methadone",
        "effect": "↓ methadone",
        "suggestion": "Adjust"
      },
      {
        "drug": "Metoprolol",
        "effect": "↓ metoprolol",
        "suggestion": "Adjust"
      },
      {
        "drug": "Moxifloxacin",
        "effect": "↓ moxifloxacin",
        "suggestion": "Monitor"
      },
      {
        "drug": "Nifedipine",
        "effect": "↓ nifedipine",
        "suggestion": "Monitor"
      },
      {
        "drug": "Nirmatrelvir/RTV",
        "effect": "↓ nirmatrelvir or ↓ ritonavir",
        "suggestion": "Co-administration contraindicated"
      },
      {
        "drug": "Nortriptyline",
        "effect": "↓ nortriptyline",
        "suggestion": "Monitor"
      },
      {
        "drug": "Phenytoin",
        "effect": "↓ phenytoin",
        "suggestion": "Monitor"
      },
      {
        "drug": "Posaconazole",
        "effect": "↓ posaconazole, ↑ rifampin",
        "suggestion": "Adjust"
      },
      {
        "drug": "Prednisone",
        "effect": "↓ prednisone",
        "suggestion": "Monitor"
      },
      {
        "drug": "Propranolol",
        "effect": "↓ propranolol",
        "suggestion": "Monitor"
      },
      {
        "drug": "Quinidine",
        "effect": "↑ rifampin, ↓ quinidine",
        "suggestion": "Monitor"
      },
      {
        "drug": "Raltegravir",
        "effect": "↓ raltegravir",
        "suggestion": "Use Rifabutin"
      },
      {
        "drug": "Rilpivirine",
        "effect": "↓ rilpivirine",
        "suggestion": "Avoid"
      },
      {
        "drug": "Risperidone",
        "effect": "↓ risperidone",
        "suggestion": "Avoid"
      },
      {
        "drug": "Tacrolimus",
        "effect": "↑ rifampin, ↓ tacrolimus",
        "suggestion": "Monitor"
      },
      {
        "drug": "Theophylline",
        "effect": "↓ theophylline",
        "suggestion": "Monitor"
      },
      {
        "drug": "Triazolam",
        "effect": "↓ triazolam",
        "suggestion": "Monitor"
      },
      {
        "drug": "Voriconazole",
        "effect": "↓ voriconazole",
        "suggestion": "Co-administration contraindicated"
      },
      {
        "drug": "Warfarin",
        "effect": "↓ warfarin",.
        "suggestion": "Avoid"
      },
      {
        "drug": "Zanubrutinib",
        "effect": "↓ zanubrutinib (Cancer Chemother Pharmacol 2020;85:391)",
        "suggestion": "Avoid"
      },
      {
        "drug": "Zidovudine",
        "effect": "↓ zidovudine",
        "suggestion": "Avoid"
      }
    ]
  },
  "comments": {
    "resistance": "Resistance can develop quickly due to single step mutations within the rpoB gene of the RNA polymerase."
  }
}
